|

The Liver Care Trial

RECRUITINGN/ASponsored by Zealand University Hospital
Actively Recruiting
PhaseN/A
SponsorZealand University Hospital
Started2023-05-08
Est. completion2026-11-01
Eligibility
Age18 Years – 110 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05855031

Summary

The goal of this clinical trial is to evaluate the efficacy of screening for liver disease with liver stiffness measurement on abstinence or light consumption after 6 months in individuals who are receiving treatment for alcohol use disorder and without a history of liver disease. The investigators will conduct a randomized controlled trial with concealed allocation comparing A) an invitation to a liver stiffness measurement, blood sampling and leaflet on alcohol-related disease (intervention) with B) an invitation to blood sampling (control). The primary outcome is 'abstinence or light consumption' (≤ 10 units/week) throughout the last months, and assessed 6 months after randomization.

Eligibility

Age: 18 Years – 110 YearsHealthy volunteers accepted
Inclusion Criteria:

* Attending outpatient treatment for alcohol use disorder (international classification of disease version 10: F102: alcohol dependence or F101: harmful alcohol use) at Novavi Køge or Novavi Roskilde
* Informed written consent

Exclusion Criteria:

* Not speaking Danish or English
* Severe liver disease (known by the participant)

Conditions7

Alcohol AbuseAlcohol Use DisorderAlcohol-Related DisordersAlcoholic Liver DiseaseAlcoholismFibrosis, LiverLiver Disease

Browse More Trials

Liver Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.